Adding digitoxin to contemporary GDMT improves clinical outcomes in patients who have HFrEF, according to results from the DIGIT-HF trial. Read more here:
#ESCCongress2025 www.tctmd.com/news/digitox...
(UPDATED) The effect size was modest, but the glycoside improved clinical outcomes when added to GDMT.
